In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 9th, 2008 | 28 | Yes |
Popular Name: 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzonitrile 4-[4-(1,3-benzodioxol-5-yl)-5-(2…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.89 | 9.8 | -12.87 | 1 | 6 | 0 | 84 | 366.38 | 3 | ↓ |
Mid Mid (pH 6-8) | 3.89 | 0.87 | -43.37 | 2 | 6 | 1 | 85 | 367.388 | 3 | ↓ |
Mid Mid (pH 6-8) | 3.89 | 9.91 | -15.26 | 1 | 6 | 0 | 84 | 366.38 | 3 | ↓ |
Lo Low (pH 4.5-6) | 3.89 | 0.76 | -39.78 | 2 | 6 | 1 | 85 | 367.388 | 3 | ↓ |
Lo Low (pH 4.5-6) | 3.89 | 0.97 | -106.93 | 3 | 6 | 2 | 86 | 368.396 | 3 | ↓ |
Lo Low (pH 4.5-6) | 3.89 | 10.21 | -42.7 | 2 | 6 | 1 | 85 | 367.388 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | WO2000061576A1 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2950 | 0.28 | Binding ≤ 10μM |
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2950 | 0.28 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 2950 | 0.28 | Binding ≤ 10μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 2950 | 0.28 | Functional ≤ 10μM |
Description | Species |
---|---|
Downregulation of TGF-beta receptor signaling | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer |